ghk cu clinical trials hair growth ghk-cu trial topical ghk-cu hair growth clinical trial topical Products – Azuré Skin ghk cu hair growth randomized

THERAPEUTIC OPTIONS Treatment for Wilson disease is lifelong and typically includes drugs such as D-penicillamine, a copper chelator that facilitates urinary excretion of copper bound to albumin, and zinc sulfate, which inhibits intestinal copper absorption

MOTS-C is on the WADA prohibited list as a peptide hormone

Possible side effects include: Injection site pain, redness, or bruising Unwanted facial or body hair growth Copper imbalance, which may cause headaches, nausea, or fatigue Flushing or histamine-type reactions in sensitive individuals Injectable copper peptides may not be appropriate for individuals with liver conditions, disorders of copper metabolism (such as Wilsons disease), or significant inflammatory sensitivity

Neutrophil function in inflammation and inflammatory diseases

Injectable or oral forms are investigational and not recognized as drugs